Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics

International Journal of Infectious Diseases

Volumn 25, Issue , 2014, Pages 170-174

  Nie, Wenjuan ^a   Duan, Hongfei ^a   Huang, Hairong ^a   Lu, Yu ^a   Bi, Dapeng ^b   Chu, Naihui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Second People's Hospital of Jinan   (China)

Author keywords

Clarithromycin; Inducible resistance; Mycobacterium abscessus subsp. abscessus; Mycobacterium abscessus subsp. bolletii; Susceptibility testing

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOXITIN; CLARITHROMYCIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; RNA 16S; RNA POLYMERASE BETA SUBUNIT; BACTERIAL PROTEIN; CHAPERONIN 60; HEAT-SHOCK PROTEIN 65, MYCOBACTERIUM; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; IN VITRO STUDY; INCUBATION TIME; MYCOBACTERIUM ABSCESSUS; NONHUMAN; PRACTICE GUIDELINE; RESAZURIN ASSAY; SEQUENCE ANALYSIS; SPECIES IDENTIFICATION; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; CLASSIFICATION; DRUG EFFECTS; GENETICS; GENOTYPING TECHNIQUE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; SPUTUM;

ANTIBIOTICS, ANTITUBERCULAR; BACTERIAL PROTEINS; CHAPERONIN 60; GENOTYPING TECHNIQUES; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PHENOTYPE; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; SPUTUM;

EID: 84903708791     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.02.014     Document Type: Article

References (33)

1. Griffith D.E. Nontuberculous mycobacterial lung disease. Curr Opin Infect Dis 2010, 23:185-190.
2. Iseman M.D., Marras T.K. The importance of nontuberculous mycobacterial lung disease. Am J Respir Crit Care Med 2008, 178:999-1000.
3. Van Ingen J., Boeree M.J., van Soolingen D., Mouton J.W. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. Drug Resist Updat 2012, 15:149-161.
4. Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
5. Daley C.L., Griffith D.E. Pulmonary non-tuberculous mycobacterial infections. Int J Tuberc Lung Dis 2010, 14:665-671.
6. Griffith D.E., Aksamit T.R. Therapy of refractory nontuberculous mycobacterial lung disease. Curr Opin Infect Dis 2012, 25:218-227.
7. Nessar R., Cambau E., Reyrat J.M., Murray A., Gicquel B. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother 2012, 67:810-818.
8. Chopra S., Matsuyama K., Hutson C., Madrid P. Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae. J Antimicrob Chemother 2011, 66:1533-1536.
9. Mukherjee T., Boshoff H., Barry C.E. Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae. J Antimicrob Chemother 2012, 67:252-253.
10. Hanna B.A., Ebrahimzadeh A., Elliott L.B., Morgan M.A., Novak S.M., Rusch-Gerdes S., et al. Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol 1999, 37:748-752.
11. Tortoli E. Impact of genetic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 2003, 16:319-354.
12. Adékambi T., Berger P., Raoult D., Drancourt M. rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. Int J Syst Evol Microbiol 2006, 56:133-143.
13. Adékambi T., Reynaud-Gaubert M., Greub G., Gevaudan M.J., La Scola B., Raoult D., Drancourt M., et al. Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia. J Clin Microbiol 2004, 42:5493-5501.
14. Koh W.J., Jeon K., Lee N.Y., Kim B.J., Kook Y.H., Lee S.H., et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 2011, 183:405-410.
15. Harada T., Akiyama Y., Kurashima A., Nagai H., Tsuyuguchi K., Fujii T., et al. Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J Clin Microbiol 2012, 50:3556-3561. Errata in: J Clin Microbiol 2013;51:736; J Clin Microbiol 2013;51:1061.
16. Mikaeili F., Kia E.B., Sharbatkhori M., Sharifdini M., Jalaliz N., Heidari Z., et al. Comparison of six simple methods for extracting ribosomal and mitochondrial DNA from Toxocara and Toxascaris nematodes. Exp Parasitol 2013, 134:155-159.
17. Kim H.Y., Yun Y.J., Park C.G., Lee D.H., Cho Y.K., Park B.J., et al. Outbreak of Mycobacterium massiliense infection associated with intramuscular injections. J Clin Microbiol 2007, 45:3127-3130.
18. Telenti A., Marchesi F., Balz M., Bally F., Böttger E.C., Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993, 31:175-178.
19. Kim H.Y., Kook Y., Yun Y.J., Park C.G., Lee N.Y., Shim T.S., et al. Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. J Clin Microbiol 2008, 46:3384-3390.
20. Springer B., Stockman L., Teschner K., Roberts G.D., Böttger E.C. Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbiol 1996, 34:296-303.
21. Mendoza-Aguilar M., Almaguer-Villagrán L., Jiménez-Arellanes A., Arce-Paredes P., Cid-Gutiérrez J.L., Rojas-Espinosa O. The use of the microplate Alamar blue assay (MABA) to assess the susceptibility of Mycobacterium lepraemurium to anti-leprosy and other drugs. J Infect Chemother 2012, 18:652-661.
22. Schröder K.H., Naumann L., Kroppenstedt R.M., Reischl U. Mycobacterium hassiacum sp. nov., a new rapidly growing thermophilic Mycobacterium. Int J Syst Bacteriol 1997, 47:86-91.
23. Springer B., Böttger E.C., Kirschner P., Wallace R.J. Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol 1995, 45:262-267.
24. Nash K.A., Brown-Elliott B.A., Wallace R.J. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 2009, 53:1367-1376.
25. Sander P., Prammananan T., Meier A., Frischkorn K., Böttger E.C., Sander P., Prammananan T., Meier A., et al. The role of ribosomal RNAs in macrolide resistance. Mol Microbiol 1997, 26:469-480.
26. Pfister P., Jenni S., Poehlsgaard J., Thomas A., Douthwaite S., Ban N., Böttger E.C., et al. The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059. J Mol Biol 2004, 342:1569-1581.
27. Akshay S., Bertea M., Hobbie S.N., Oettinghaus B., Shcherbakov D., Böttger E.C., Akbergenov R., et al. Phylogenetic sequence variations in bacterial rRNA affect species-specific susceptibility to drugs targeting protein synthesis. Antimicrob Agents Chemother 2011, 55:4096-4102.
28. Pfister P., Corti N., Hobbie S., Bruell C., Zarivach R., Yonath A., Böttger E.C., et al. 23S rRNA base pair 2057-2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G. Proc Natl Acad Sci U S A 2005, 102:5180-5185.
29. Böttger E.C., Springer B., Prammananan T., Kidan Y., Sander P., et al. Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep 2001, 2:318-323.
30. Meier A., Kirschner P., Springer B., Steingrube V.A., Brown B.A., Wallace R.J., Böttger E.C., et al. Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob Agents Chemother 1994, 38:381-384.
31. Nash K.A., Inderlied C.B. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother 1995, 39:2625-2630.
32. Wallace R.J., Meier A., Brown B.A., Zhang Y., Sander P., Onyi G.O., Böttger E.C., et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996, 40:1676-1681.
33. Bastian S., Veziris N., Roux A.L., et al. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother 2011, 55:775-781.